Kardium Inc. is a rapidly growing Canadian medical solutions company that has developed the Globe Mapping and Ablation System for the treatment of atrial fibrillation (AF), which affects more than 37 million people worldwide.

Kardium's Globe® Pulsed Field Mapping and Ablation System is the most complete PFA solution for AFib, offering single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation – all in a single catheter.

At Kardium, we have worked hard to build an exceptional team with expertise in medicine, business, engineering, quality and manufacturing.

Kardium Inc. is a rapidly growing medical solutions company that has developed an advanced system for the treatment of atrial fibrillation (AF), which affects more than 59 million people worldwide. The Globe ® Mapping and Ablation System is the most complete solution for AF, offering single-shot pulmonary vein isolation, high-definition ...

(Vancouver | May 31, 2023) Kardium Inc., a private medical device company that has developed the Globe System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), …

06/11/2024: Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment. 05/29/2024: Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the treatment of atrial fibrillation

2023年3月15日 · “The whole team at Kardium is thrilled to be starting the PULSAR study,” said Kardium CEO Kevin Chaplin. “We believe the Globe System has the potential to improve …

2021年12月15日 · First-in-Human Trial of Pulsed Field Ablation with Kardium’s Globe® PF System │ Pulsed Field Ablation (PFA): Promising new therapy to treat the world’s most common heart rhythm disorder, atrial fibrillation (AF).

2024年6月11日 · VANCOUVER, British Columbia —Kardium Inc., developer of the Globe ® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $104 million in a new financing round. The round is led by existing investor Fidelity Management & Research Company, together with follow-on participation by funds and accounts advised by T ...

2021年1月25日 · Kardium announces $115M in new financing for innovative atrial fibrillation treatment Fidelity Management & Research Company LLC and T. Rowe Price funds lead private financing round. 01/25/2021